A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial

Etienne Minvielle (), Henri Leleu, Marc Masseti, Arlindo Ferreira, Mario Di Palma, Florian Scotté () and Gérard de Pouvourville ()
Additional contact information
Etienne Minvielle: DIOPP - Département interdisciplinaire d’organisation des parcours patients - IGR - Institut Gustave Roussy, CRG I3 - Centre de recherche en gestion I3 - X - École polytechnique - IP Paris - Institut Polytechnique de Paris - I3 - Institut interdisciplinaire de l’innovation - CNRS - Centre National de la Recherche Scientifique
Henri Leleu: Public Health Expertise [Paris, France]
Marc Masseti: Public Health Expertise [Paris, France]
Arlindo Ferreira: Resilience
Mario Di Palma: DIOPP - Département interdisciplinaire d’organisation des parcours patients - IGR - Institut Gustave Roussy
Florian Scotté: DIOPP - Département interdisciplinaire d’organisation des parcours patients - IGR - Institut Gustave Roussy
Gérard de Pouvourville: ESSEC Business School

Post-Print from HAL

Abstract: Background/objectives: Remote patient monitoring (RPM) has demonstrated numerous benefits in cancer care, including improved quality of life, overall survival, and reduced medical resource use. This study presents a budget impact analysis of a nurse navigator-led RPM program, based on the CAPRI trial, from the perspective of the French national health insurance (NHI). The study aimed to assess the impact of the program on medical resource utilization and costs. Methods: Medical resource utilization data were collected from both medico-administrative sources and patient-reported questionnaires. Costs were calculated by applying unit costs to resource utilization and estimating the average monthly cost per patient. Sensitivity analyses were conducted to explore different perspectives and varying resource consumption. Results: The analysis included 559 cancer patients participating in the CAPRI program. From the NHI perspective, the program resulted in average savings of €377 per patient over the 4.58-month follow-up period, mainly due to reduced hospitalizations. The all-payers perspective yielded even greater savings of €504 per patient. Sensitivity analyses supported the robustness of the findings. Conclusion: The budget impact analysis demonstrated that the CAPRI RPM program was associated with cost savings from the perspective of the NHI. The program's positive impact on reducing hospitalizations outweighed the additional costs associated with remote monitoring. These findings highlight the potential economic benefits of implementing RPM programs in cancer care. Further research is warranted to assess the long-term cost-effectiveness and scalability of such programs in the real-world settings.

Keywords: Budget impact analysis; Cancer care; Cost savings; Medical resource utilization; Remote patient monitoring (search for similar items in EconPapers)
Date: 2024-06-28
References: Add references at CitEc
Citations:

Published in European Journal of Health Economics, inPress, ⟨10.1007/s10198-024-01702-1⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04859778

DOI: 10.1007/s10198-024-01702-1

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().